Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
ACS Chemical Neuroscience|July 11, 2012
Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567Scott D Kuduk, Christina N Di Marco, Vera Bodmer-Narkevitch, et al.Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacementsKaren M Brashear, Cecilia A Hunt, Brian T Kucer, et al.ACS Medicinal Chemistry Letters|July 24, 2018
MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development CandidateDouglas C Beshore, Christina N Di Marco, Ronald K Chang, et al.Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolaseAntonella Converso, Timothy Hartingh, Mark E Fraley, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.Bioorganic & Medicinal Chemistry Letters|January 11, 2007
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHAZhijian Zhao, David D Wisnoski, Julie A O'Brien, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 ReceptorRobert M Garbaccio, Edward J Brnardic, Mark E Fraley, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 4: potent and orally bioavailable chain-shortened RGD mimeticsPaul J Coleman, Ben C Askew, John H Hutchinson, et al.Bioorganic & Medicinal Chemistry Letters|March 1, 2012
Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation ratesVadim Y Dudkin, Keith Rickert, Constantine Kreatsoulas, et al.Pageof 12